Next Century Growth Investors LLC Neuronetics, Inc. Transaction History

Next Century Growth Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.22 - $15.54 $4.3 Million - $10.7 Million	-690,658 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$10.15 - $17.25 $1.04 Million - $1.76 Million	-102,047 Reduced 12.87%	690,658 $11.1 Million
Q1 2021 May 14, 2021	BUY	$10.6 - $21.27 $8.4 Million - $16.9 Million	792,705 New	792,705 $9.81 Million
Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $1.23 Million - $2.35 Million	-136,367 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$13.6 - $19.58 $1.41 Million - $2.03 Million	-103,805 Reduced 43.22%	136,367 $2.08 Million
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $2.33 Million - $4.65 Million	145,931 Added 154.85%	240,172 $4.65 Million
Q3 2018 Nov 14, 2018	SELL	$24.32 - $37.54 $79,258 - $122,342	-3,259 Reduced 3.34%	94,241 $3.02 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $2.59 Million - $2.71 Million	97,500 New	97,500 $2.59 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $30M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.